Willow Biosciences announces second collaboration with leading API manufacturer
Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF) announced a second program with a leading Active Pharmaceutical Ingredient (API) manufacturer to develop a...
Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF) announced a second program with a leading Active Pharmaceutical Ingredient (API) manufacturer to develop a...
Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF) has struck a commercial license and royalty agreement with Kalsec, a global producer of natural ingredients...
Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF) CEO Dr Chris Savile told Proactive he is confident that Willow is on track to meet its revenue targets after...
Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF) has reported higher revenue and reduced costs for the second quarter and now anticipates achieving more than...